Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, N
Recalled March 11, 2026 · FDA recall D-0357-2026 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications · FDA Class II
Units
19,056 bottles
Sold at
Nationwide
Description
Failed Dissolution Specifications
Product
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Manufacturer(s)
Teva Pharmaceuticals USA, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →